Low risk of human T-lymphotropic virus infection in U.S. blood donors; Is it time to consider a one-time selective testing approach?

Transfusion(2023)

引用 0|浏览10
暂无评分
摘要
HTLV donation seroprevalence for the years 2008-2021 varied by virus type and donor characteristics. Low HTLV residual risk and use of leukoreduction processes support the conclusion that a selective one-time donor testing strategy should be considered.
更多
查看译文
关键词
HTLV-1,HTLV-2,blood donation testing,blood safety,incidence,residual risk,seroprevalence
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要